On June 24, 2025, InMed Pharmaceuticals Inc. entered into a securities purchase agreement to sell 1,952,363 common shares at $2.561 each, raising approximately $5 million; the deal closed on June 26, 2025. Additionally, short-term preferred investment options were issued, allowing purchases at an exercise price of $2.436 per share.